In the present study, we quantified mRNA expression levels of KLK10 and KLK11 in a well-defined cohort of patients afflicted with triple-negative breast cancer, and evaluated their potential as prognostic factors. This evidence concerns the gene KLK11 and triple-negative breast carcinoma.